Cocrystal Pharma, Inc. (COCP)
Largest Insider Buys in Sector
COCP Stock Price History Chart
COCP Stock Performance
About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials …
Insider Activity of Cocrystal Pharma, Inc.
Over the last 12 months, insiders at Cocrystal Pharma, Inc. have bought $0 and sold $0 worth of Cocrystal Pharma, Inc. stock.
On average, over the past 5 years, insiders at Cocrystal Pharma, Inc. have bought $1.02M and sold $1.7M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,015,229 shares for transaction amount of $2M was made by FROST PHILLIP MD ET AL () on 2023‑04‑04.
List of Insider Buy and Sell Transactions, Cocrystal Pharma, Inc.
| 2023-04-04 | 1.02M 11.981% | $1.97 | $2M | -6.34% | ||||
| 2021-08-20 | director | 40,000 0.0414% | $1.03 | $41,120 | -46.08% | |||
| 2021-05-04 | Sale | 10 percent owner | 575,000 0.9104% | $2.95 | $1.7M | -56.54% | ||
| 2019-10-25 | 10 percent owner | 7,906 0.0202% | $1.15 | $9,092 | -14.81% | |||
| 2019-10-24 | 10 percent owner | 5,094 0.0122% | $1.15 | $5,858 | -20.00% | |||
| 2019-10-23 | 10 percent owner | 3,935 0.0085% | $1.04 | $4,087 | -20.00% | |||
| 2016-12-23 | Sale | 2.2M 0.343% | $0.44 | $968,000 | -37.50% | |||
| 2016-09-01 | 10,000 0.0015% | $0.41 | $4,100 | -30.00% | ||||
| 2016-09-01 | 4.88M 0.7103% | $0.41 | $2M | -30.00% | ||||
| 2016-09-01 | 10,000 0.0015% | $0.41 | $4,100 | -30.00% | ||||
| 2016-03-15 | 2.94M 0.3532% | $0.51 | $1.5M | -22.95% | ||||
| 2016-03-15 | 2.94M 0.3532% | $0.51 | $1.5M | -22.95% | ||||
| 2016-03-15 | 49,020 0.0059% | $0.51 | $25,000 | -22.95% | ||||
| 2016-03-15 | 1.24M 0.1484% | $0.51 | $630,000 | -22.95% | ||||
| 2016-03-15 | 39,216 0.0047% | $0.51 | $20,000 | -22.95% | ||||
| 2016-03-15 | 294,118 0.0353% | $0.51 | $150,000 | -22.95% | ||||
| 2016-03-15 | 50,000 0.006% | $0.51 | $25,500 | -22.95% | ||||
| 2015-12-23 | 100,000 0.0151% | $0.58 | $57,870 | -3.64% | ||||
| 2015-04-21 | 3.46M 0.4605% | $0.92 | $3.19M | -26.00% | ||||
| 2015-03-25 | 3.46M 0.4593% | $0.92 | $3.19M | -22.77% |
Insider Historical Profitability
| WILCOX GARY | 16948605 166.5907% | $2.19 | 3 | 0 | ||
| Schinazi Raymond F | 10 percent owner | 7674960 75.4385% | $2.19 | 6 | 1 | <0.0001% |
| HSIAO JANE PH D | 3435294 33.7661% | $2.19 | 2 | 0 | ||
| FROST PHILLIP MD ET AL | 1319838 12.9729% | $2.19 | 6 | 0 | <0.0001% | |
| Rubin Steven D | 733484 7.2095% | $2.19 | 2 | 0 |